Shorter dosing interval of opiate solution shortens hospital stay for methadone babies
- PMID: 10407710
Shorter dosing interval of opiate solution shortens hospital stay for methadone babies
Abstract
Background and objectives: Methadone maintenance is the standard of care for pregnant opiate addicts. However, withdrawal of an infant from methadone after birth often results in a lengthy hospital stay. This study identified potentially modifiable factors that are associated with the length of hospital stay of infants of mothers on methadone.
Methods: This study used a retrospective case series of patients from a university hospital in Texas. Eligible participants included 41 neonates born between January 1991 and December 1996 to mothers taking methadone at time of delivery. Charts were reviewed for factors relating to administration of opiates to the newborn, and the length of the hospital stay was recorded for each infant. Bivariate and multiple regression analyses were performed using length of hospital stay as the outcome measure.
Results: Higher peak dose of tincture of opiate solution (TOS) and longer dosing interval were found to be related to longer length of hospital stay. These variables explained 23% of the variation in length of stay.
Conclusions: Lower peak doses of TOS and shorter dosing intervals may be associated with shorter hospital stays for infants with neonatal abstinence syndrome secondary to maternal methadone treatment.
Similar articles
-
A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.Adv Neonatal Care. 2005 Oct;5(5):265-72. doi: 10.1016/j.adnc.2005.06.003. Adv Neonatal Care. 2005. PMID: 16202968
-
Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.J Perinat Med. 2007;35(4):344-6. doi: 10.1515/JPM.2007.063. J Perinat Med. 2007. PMID: 17511598
-
Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.BJOG. 2009 Apr;116(5):665-71. doi: 10.1111/j.1471-0528.2008.02073.x. Epub 2009 Feb 10. BJOG. 2009. PMID: 19220239
-
Pharmacologic management of neonatal abstinence syndrome in a community hospital.Clin Obstet Gynecol. 2013 Mar;56(1):193-201. doi: 10.1097/GRF.0b013e31827adf91. Clin Obstet Gynecol. 2013. PMID: 23314713 Review.
-
[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S31-6. Ann Med Interne (Paris). 2002. PMID: 12518080 Review. French.
Cited by
-
Pharmacologic management of the opioid neonatal abstinence syndrome.Pediatr Clin North Am. 2012 Oct;59(5):1147-65. doi: 10.1016/j.pcl.2012.07.006. Epub 2012 Aug 30. Pediatr Clin North Am. 2012. PMID: 23036249 Free PMC article. Review.
-
The opioid-exposed newborn: assessment and pharmacologic management.J Opioid Manag. 2009 Jan-Feb;5(1):47-55. J Opioid Manag. 2009. PMID: 19344048 Free PMC article. Review.
-
Neonatal Abstinence Syndrome.Pediatr Clin North Am. 2019 Apr;66(2):353-367. doi: 10.1016/j.pcl.2018.12.006. Pediatr Clin North Am. 2019. PMID: 30819342 Free PMC article. Review.